CRISPR/Cas9 editing of E. coli engineered bacteria for the production of glucosamine

Glucosamine (GlcN) and N-acetylglucosamine (GlcNAc) are important precursor substances for the synthesis of glycosaminoglycans, with extensive application value in many fields. Microbial fermentation has many advantages in the production of GlcN and GlcNAc, and is increasingly favored. This study constructed genetically engineered strains of Escherichia coli with high production of GlcN and GlcNAc, laying the…

Read More

Nature catalysis | Production of natural products through Escherichia coli metabolic engineering using electronic channels

Research background: The biosynthesis of natural products usually requires the binding of eukaryotic cytochrome P450 (P450) to P450 reductase, which is physically close and undergoes electron transfer reactions. Research question: Unfortunately, the functional expression of eukaryotic p450 in bacteria is often still difficult. Research content and results: 1) The author of this article artificially approached…

Read More

The Path to Fame of Escherichia coli

Theodor Escherich, an outstanding physician and scientist of the 19th century, was one of the earliest scientists to explore microorganisms. He founded the field of intestinal pathology and associated his name with the name Escherichia coli, which was discovered and named in 1885. From then on, the “E.coli clan” was endowed with the fate of…

Read More

New Achievements in Cell Genomics Construction of Artificial Synthetic Yeast, Revealing Two Different Pathways of Non ploidy Phenotypic Restoration

  In 2011, countries such as the United States, China, the United Kingdom, Singapore, and Australia launched the “Sc2.0 Project” to redesign and synthesize all 16 chromosomes of brewing yeast. This was the first attempt by humans to design and synthesize the genome of eukaryotes from scratch. On November 8, 2023, the latest research findings…

Read More

The first CRISPR therapy has been approved, and which new round of gene editing is about to enter the clinical trial stage?

Less than a month after the world’s first approval of CRISPR-Cas9 genome editing therapy, this therapy received a second approval – this time from the United States, due to its strict regulation and lucrative healthcare market. The UK regulatory agency approved this therapy on November 16th, which inactivates a gene as a means of treating…

Read More

Improving Protein Stability and Mutation Based on Machine Learning Guidance

Engineering proteins that enhance stability are widely used in the development of biological therapies or diagnostic reagents, as well as in other commercial and industrial applications. For this reason, many related experimental and computational methods have been developed, such as directed evolution, rational design, ancestor sequence reconstruction, and molecular dynamics simulation, which stabilize proteins by…

Read More

Nat Microbiol | Streptomyces derived polyketide compounds are signaling molecules that mediate the interaction between bacteria and fungi in soil environments

As is well known, microorganisms can produce abundant secondary metabolites and are an important source for drug development. Streptomyces is a star species in the development and research of microbial drugs, and many medical or agricultural antibiotics such as rapamycin (immunosuppressive agent), nystatin (antifungal), avermectin (insecticidal), and azamycin (antibacterial) are produced from Streptomyces. However, the…

Read More

Transforming Escherichia coli to achieve efficient production of 3-hydroxypropionic acid from glycerol

Research background: The use of renewable substrates such as glycerol to produce 3-HP is a promising method. However, the production of 3-HP from glycerol requires vitamin B-12, which hinders its economic feasibility. Research has shown that using glycerol as a substrate β- The alanine pathway can efficiently produce 3-HP. Therefore, a comparison was made between…

Read More